Valeriee De Abreu

Leading emitter production and cleanroom operations for a disruptive MedTech startup. Specializing in the transition from R&D to manufacturing by bridging technical materials engineering with operational scaling

Successfully doubled weekly production throughput (100% increase) by standardizing complex R&D workflows. Achieved this growth using existing laboratory resources and optimized personnel allocation, proving scalability before capital infusion.

Engineered process improvements that surged raw material yield from ~50% to 90%. This optimization significantly reduced unit costs and material waste, directly improving the venture’s gross margin profile.

Currently leading the "Phase 2" expansion to double capacity again by identifying and neutralizing critical infrastructure bottlenecks (High Vacuum pump / furnace capacity) and architecting the human capital roadmap.

Serve as the central "Business-to-Tech" bridge, aligning emitter design, supplier management, and quality assurance. Represent the department in front of high management and external audits to translate technical milestones into investor-ready insights.

Supervise and mentor a multidisciplinary team within cleanroom environments, ensuring 100% compliance with medical and security regulatory standards while maintaining a high-performance culture under tight delivery milestones.

Manage the full product lifecycle from requirements definition to customer delivery, "wearing many hats" to ensure operational resilience in a fast-paced startup environment.

Analyzed and upgraded existing manufacturing workflows for Field Emission Cathodes. These improvements directly impacted the integration of Nanotube-based Multi-Beam X-ray (MBX) technology into high-value medical systems (Breast Tomosynthesis and Portable CT).

Systematically optimized production parameters, achieving a 30% increase in raw material yield and a 17% reduction in lead time through the application of advanced materials science and data-driven testing.

Led the Root Cause Analysis (RCA) initiatives that reduced emitter failure rates by 30%. Transformed a high-variance research process into a stable, repeatable workflow.

Acted as the primary bridge between the R&D lab and Senior Management. Translated complex technical milestones, risks, and process improvements into clear, actionable insights for executive decision-making.

Conducted characterization of nanotube emitters (surface morphology and emission stability) to ensure device reliability met stringent industrial and medical standards.

Improved the purification and synthesis of nanotube materials, establishing the quality benchmarks necessary for high-vacuum electronic components.

Researched advanced polymer materials to drive the development of sustainable and high-efficiency plastic products, aligning scientific properties with industrial performance requirements.

Delivered insights and data-driven findings to cross-functional stakeholders, ensuring the alignment of research goals with commercial product sustainability targets.